EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial

En-Ling Wu iD, Makenna Meyer, Ellen Almirol, Xiaoquan Zhao iD, Gjvar Payne, Kavita Bhavan, Nickolas Zaller, Jerome Montgomery, Anna Hotton, Russell Brewer, Michelle M Johns, Matthew C Aalsma und 21 weitere

Journal of Public Health · 2025

DOI: 10.1093/pubmed/fdaf134 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Public Health, 2025. Verfasst von En-Ling Wu und 32 weiteren Autor:innen. Beteiligte Einrichtung: Division of the Biological Sciences, The University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: COVID-19, Vulnerable Populations, COVID-19 Testing, Community Networks. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institutes of Health RADx-UP, NIDA’s Justice Community Overdose Intervention Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Community Network-Driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central United States (C3) evaluates the use of Social Network Strategy (SNS) with educational messaging to improve COVID-19 testing and vaccination among people most impacted by the pandemic.

Methods

We enrolled individuals with low-income who identify as Hispanic/Latino or a history of criminal legal involvement (CLI) through social network referral and randomized participants 1:1 to SNS vs. SNS plus messaging (SNS+), which included a self-affirmation activity and educational video. We assessed for COVID-19 testing and, among baseline unvaccinated participants, vaccination at 21 days, and used mixed effects logistic regression to examine outcomes.

Results

Of 1328 participants (SNS+: 667, SNS: 661), 46.6% identified as Black/African American, 33.4% as Hispanic/Latino, and 43.8% reported history of CLI. Majority (66.3%) reported testing and, of unvaccinated participants, 11.9% reported vaccination at follow-up. There were no differences in testing (aOR 0.89, 95% CI 0.71, 1.11, P = .49) or vaccination (aOR 1.46, 95% CI 0.78, 2.76, P = .30) among participants who received SNS+ compared to SNS after adjusting for recruitment wave and clustering within sites and referral chains.

Conclusions

Social network referral successfully engaged communities disproportionately impacted by COVID-19 in testing and vaccination. Compared to SNS alone, adding educational messaging did not increase testing or vaccination. Additional work is needed to implement SNS to increase vaccination rates among vulnerable populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Vulnerable PopulationsCOVID-19 TestingCommunity NetworksCOVID-19 VaccinesVaccinationSocial NetworkingHumansMaleFemaleAdultMiddle AgedHispanic or LatinoSARS-CoV-2United StatesPovertyWhite

Stichwörter der Autor:innen

Black/African AmericanCOVID-19 testingCOVID-19 vaccinesHispanic/Latinocriminal legal involvementsocial network strategy

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Division of the Biological Sciences, The University of Chicago, Chicago, IL 60637, USA.
  • Department of Statistics, NC State University, Raleigh, NC 27695, USA.
  • Department of Communication, George Mason University, Fairfax, VA 22030, USA.
  • Capitol Area Reentry Program Inc., Baton Rouge, LA 70806, USA.
  • Parkland Health, Dallas, TX 75235, USA.
  • Department of Health Behavior and Health Education, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

ORCID-Profile: En-Ling Wu, Xiaoquan Zhao, Aniruddha Hazra, John A Schneider

Förderung

  • NIDA NIH HHS
  • National Institutes of Health RADx-UP
  • NIDA’s Justice Community Overdose Intervention Network

Zitieren

APA

Wu, E. L., Meyer, M., Almirol, E., Zhao, X., Payne, G., Bhavan, K., Zaller, N., Montgomery, J., Hotton, A., Brewer, R., Johns, M. M., Aalsma, M. C., Knopf, A. S., Hodge, S., Johnson, O., Carter, C. C., Bucala, M., Hazra, A., Shah, M., …, & Schneider, J. A. (2025). A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial. Journal of Public Health. https://doi.org/10.1093/pubmed/fdaf134

Vancouver

Wu EL, Meyer M, Almirol E, Zhao X, Payne G, Bhavan K, et al. A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial. Journal of Public Health. 2025. doi:10.1093/pubmed/fdaf134

BibTeX
@article{Wu2025,
  author = {Wu, En-Ling and Meyer, Makenna and Almirol, Ellen and Zhao, Xiaoquan and Payne, Gjvar and Bhavan, Kavita and Zaller, Nickolas and Montgomery, Jerome and Hotton, Anna and Brewer, Russell and Johns, Michelle M and Aalsma, Matthew C and Knopf, Amelia S and Hodge, Sarah and Johnson, O'Dell and Carter, Chandler C and Bucala, Matthew and Hazra, Aniruddha and Shah, Monal and Pho, Mai T and Bouris, Alida and Walters, Suzan M and Umutoni, Victoria and Pyra, Maria and Birkett, Michelle and Phillips, Gregory and Zapolski, Tamika C B and Webb, Jeannette and Smartt, Jillian and Horton, Heather and Durrell, Mainza and Fletcher, Scott and Schneider, John A},
  title = {A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial},
  journal = {Journal of Public Health},
  year = {2025},
  doi = {10.1093/pubmed/fdaf134}
}
Kostenlos starten →